IL6 and intrahepatic cholangiocarcinoma: Furthermore, these hepatolithiasis‐related ICC patients exhibited significant changes in Interleukin‐6 (IL‐6) levels in the bile, which is consistent with studies showing a substantial role of IL‐6 in ICC progression[25, 26] (Figure S1A, Supporting Information).